VitalHub Selected 10th in 2020 Deloitte Technology Fast 50™ Program
TORONTO, Nov. 18, 2020 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce that...
Day: November 18, 2020
What do the Pfizer Vaccine and BetterLife Pharma have in common?
New York City, Nov. 18, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB:...
Better Choice Company Reports Third Quarter and Year-to-Date 2020 Financial Results
NEW YORK, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (OTCQB: BTTR) (the “Company” or “Better Choice”), an...
Indus Holdings, Inc. Announces Preliminary Expansion Plans
The Company takes first step in its expansion with the addition of a 300,000 sq. ft. facility within Monterey County...
Syneos Health Announces Senior Notes Offering
MORRISVILLE, N.C., Nov. 18, 2020 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only...
Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints
Primary efficacy analysis demonstrates BNT162b2 to be 95% effective against COVID-19 beginning 28 days after the first dose; 170 confirmed...
Revive Therapeutics Announces Research Collaboration with PharmaTher for Development of Psilocybin in Cancer and Discovery of Novel Uses of Psychedelics
TORONTO, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive”) (CSE: RVV, USA: RVVTF), a specialty life sciences company...
Medicenna Announces Upcoming Oral Presentations at the 2020 Society for Neuro-Oncology Annual Meeting
TORONTO and HOUSTON, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. ("Medicenna" or “the Company") (NASDAQ: MDNA TSX: MDNA),...
ProQR to Present at 3rd Annual Evercore ISI Virtual HealthCONx Conference
LEIDEN, Netherlands & CAMBRIDGE, Mass., Nov. 18, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company...
Chiasma Announces Positive Topline Results from the MPOWERED™ Phase 3 Clinical Trial Comparing MYCAPSSA® (octreotide capsules) to Long Acting Injectables for the Maintenance Treatment of Adults with Acromegaly
91% of patients on MYCAPSSA maintained IGF-1 response in the 9-month randomized, controlled phase of the non-inferiority trial Company intends...
G1 Therapeutics to Present Clinical Data on Trilaciclib and Rintodestrant at 2020 San Antonio Breast Cancer Symposium (SABCS)
RESEARCH TRIANGLE PARK, N.C., Nov. 18, 2020 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today...
Multiple New VASCEPA® (Icosapent Ethyl)-Related Scientific Findings Presented at American Heart Association’s Virtual Scientific Sessions 2020
Findings further support the differentiated multifactorial mechanism of action of VASCEPA and its robust clinical effectiveness in reducing major adverse...
Samsung Bioepis and Biogen Announce FDA Filing Acceptance of SB11, A Proposed Biosimilar Referencing Lucentis® (ranibizumab)
INCHEON, South Korea and CAMBRIDGE, Mass., Nov. 18, 2020 (GLOBE NEWSWIRE) -- Samsung Bioepis Co., Ltd. and Biogen Inc. (Nasdaq:...
Brickell Biotech Announces Launch Date for Sofpironium Bromide Gel, 5% (ECCLOCK®) in Japan by its Development Partner, Kaken Pharmaceutical
Kaken plans to launch ECCLOCK®for the treatment of primary axillary hyperhidrosis in Japan on November 26, 2020- - -ECCLOCK®placed on...
BrainsWay Reports Third Quarter 2020 Financial Results and Operational Highlights
CRESSKILL, N.J. and JERUSALEM, Israel, Nov. 18, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the...
Pluristem to Present Initial Results from Its Phase I HCT Study with PLX-R18 Demonstrating Safety and Efficacy at the ASH Annual Meeting
PLX-R18 demonstrated significant clinical improvements in Hb, ANC, and PLT among the high-dose cohort PLX-R18 was found to be safe...
The Fondation Famille Michel Fournelle renews its support to the Fondation Dr Julien with a donation of $5 million over 5 years
Fondation Dr. Julien From left to right: Hélène (Sioui) Trudel, Lawyer – Accredited Mediator, Director of Integrated Law and Social...
Nexstim Plc signs a purchase agreement worth EUR 0.9 million to develop and deliver two prototype systems for a research project
Company announcement, Inside information, Helsinki, 18 November 2020 at 11.00 am (EET) Nexstim Plc signs a purchase agreement worth EUR...
Positive results from Acarix study presented at ISPOR, a leading health economics conference
Press releaseMalmö, Sweden November 18, 2020 Positive results from Acarix study presented at ISPOR, a leading health economics conference Acarix...
BioPorto Announces Q3 2020 Report
November 18, 2020Announcement no. 21Q3 2020 ReportHighlights BioPorto will this week initiate patient enrollment for trial of its COVID-19 rapid...